APPLICATION OF NIFURATOL FOR TREATING INFECTIONS CAUSED BY CLOSTRIDIUM TYPES

摘要

The present invention relates to the use of nifuratel or its physiologically acceptable salt for the treatment of infections caused by species of bacteria of the genus Clostridium. The invention also relates to the use of nifuratel for the treatment of Clostridium difficile infection (CDI) and, in particular, Clostridium difficile associated diarrhea (CDAD).